NEWS

Product innovation & physician training never stands still

Empowering the future of interventional neuroradiology practice together - Day 3

Surpass Evolve 2-year follow-up

Discover a stimulating experience - DAY 2 in Paris

LINNC Paris 2021, Together…again!

Sensome begins human trial for its AI-powered stroke guidewire

Paris, France - September 13th, 2021 - Sensome, the company pioneering the connected medical device revolution with the world’s smallest biological tissue sensor, announced today that Gold Coast University Hospital (GCUH) in Australia enrolled the first patients in the Company’s CLOT OUT first-in-human study evaluating safety and performance of the Clotild® Smart Guidewire System in large-vessel acute ischemic stroke patients.

Transmission of 2 live INR procedures using robotics

Treating an Acom aneurysm using flow diversion

Wallaby Medical partners with Brainomix to bring the most comprehensive...

SHANGHAI, CHINA – August 26, 2021 -  Wallaby Medical (“Wallaby”), a rapidly growing medical device company focused on developing and commercializing medical device products for treating stroke, and Brainomix Limited (“Brainomix”), a UK-headquartered company that specializes in the creation of AI-powered imaging biomarkers and software solutions that enable precision medicine for better treatment decisions, announced the signing of a new distribution agreement. As part of the agreement, Wallaby will distribute Brainomix’s e-Stroke software to stroke centres across Greater China.

Cerebellar AVM with occipital artery and PICA feeding